Skip to search formSkip to main contentSkip to account menu

Ecabet sodium

Known as: 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ecabet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
H pylori eradication: a randomized prospective study of triple therapy with or without ecabet sodium.
AIM To investigate whether adding ecabet sodium to the standard triple therapy for H pylori infection improve eradication rate… 
2005
2005
Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells.
Helicobacter pylori LPS activates a homolog of gp91(phox), NADPH oxidase 1 (Nox1), in guinea pig gastric mucosal cells cultured… 
2003
2003
Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: Prospective randomized multicenter study
Background and Aim:  Little is known about the clinical efficacy of cotherapy of ecabet sodium, a mucoprotective agent, and a… 
2001
2001
Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
Pepsin, acid and Helicobacter pylori are major factors in the pathophysiology of peptic ulcer disease and reflux oesophagitis… 
2000
2000
Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8
Abstract: The pathogenic role of human neutrophils has been implicated in Helicabacter pylori-associated gastritis. Ecabet sodium… 
1996
1996
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Ecabet sodium (ecabet), a new agent that has protective effects on the gastric mucosa has anti-Helicobacter pylori effects… 
1995
1995
Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats
The present study was designed to examine the relationship between the gastroprotective efficacy of the locally acting antiulcer… 
1993
1993
Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. II. Interaction with substrate protein.
To define the mechanism of the protection by ecabet (TA-2711) of the gastric mucosa from peptic attack, the characteristics of… 
1993
1993
Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein.
To investigate the mechanism of the anti-peptic action of ecabet sodium (TA-2711) observed in pylorous-ligated rats, effects of… 
1993
1993
Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats.
Effects of ecabet sodium (TA-2711), a locally acting antiulcer agent, on prostanoid production and the morphology of the rat… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)